PWMG
IRWD icon

Private Wealth Management Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

Private Wealth Management Group’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-82
Closed -$338 – 1539
2024
Q3 		$338 Sell
82
-509
-86% -$2.74K ﹤0.01% 1454
2024
Q2 		$3.85K Buy
+591
New +$4.18K ﹤0.01% 813
2024
Q1 		– Sell
-114
Closed -$1.3K – 1547
2023
Q4 		$1.3K Buy
+114
New +$1.13K ﹤0.01% 1170

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Private Wealth Management Group's IRWD Position: Q4 2024 in Review

Private Wealth Management Group sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2024, closing a stake of 82 shares — an estimated $338 sold.

Private Wealth Management Group first reported a position in IRWD in Q4 2023 and held it in 3 quarters. The position peaked at $3.85K in Q2 2024. 223 funds tracked by Wall St. Rank hold IRWD as of Q4 2024.

  • Private Wealth Management Group reported no remaining Ironwood Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Private Wealth Management Group sold 82 Ironwood Pharmaceuticals shares in Q4 2024, an estimated $338.
  • Private Wealth Management Group first reported a position in Ironwood Pharmaceuticals in Q4 2023 and held it in 3 quarters.
  • Private Wealth Management Group's Ironwood Pharmaceuticals position peaked at $3.85K in Q2 2024.
  • 223 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2024.

Based on Private Wealth Management Group's 13F filing for Q4 2024, filed 27 Jan 2025.